title: Immediate reduction of white blood cell count after tocilizumab administration was observed in some cases.
authors.affiliation: Department of Orthopaedic Surgery, Yoshizuka Hayashi Hospital, Hakata-ku, Fukuoka, Japan. r_nagamine@kyorinkai.or.jp
authors.forename: Ryuji
authors.initials: R
authors.lastname: Nagamine
authors.forename: Weijia
authors.initials: W
authors.lastname: Chen
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Hara
authors.forename: Keiichi
authors.initials: K
authors.lastname: Kondo
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Sugioka
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D015331:Cohort Studies; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced*; D008875:Middle Aged; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D019947:Receptors, Interleukin-6; C502936:tocilizumab